Role of methylglyoxal in essential hypertension

International Journal of Angiology

Volumn 19, Issue 2, 2010, Pages

  Vasdev, Sudesh ^a   Stuckless, Jennifer ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Dietary antioxidants; Hypertension; Methylglyoxal

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM CHANNEL; CALCIUM ION; CYSTEINE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; METHYLGLYOXAL; NITRIC OXIDE; PYRIDOXINE; THIOCTIC ACID;

ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; BIOSYNTHESIS; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CYTOSOL; DIABETES MELLITUS; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TISSUE LEVEL;

EID: 80053029193     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278375     Document Type: Review

References (90)

1. Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991;90(2A):7S-12S.
2. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Eng J Med 1987;317:350-7. (Pubitemid 17118813)
3. Levy J, Zemel MB, Sowers JR. Role of cellular calcium metabolism in abnormal glucose metabolism, and diabetic hypertension. Am J Med 1989;87(6A):7S-16S. (Pubitemid 20013341)
4. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 1998;181:1-9. (Pubitemid 28127772)
5. Vasdev S, Mian T, Ford CA, Longerich L, Parai S. Role of aldehydes in spontaneously hypertensive rats and disulfiram-induced hypertensive rats. Nutr Metab Cardiovasc Dis 1996;6:130-40. (Pubitemid 126545340)
6. Bolli P, Erne P, Hulthen UL, et al. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and ß-adrenoreceptor blockade. J Cardiovasc Pharmacol 1984;6:S996-S1001. (Pubitemid 15085418)
7. Alexander MC, Lomanto M, Nasrin N, Ramaika C. Insulin stimulates glyceraldehydes-3-phosphate dehydrogenase gene expression through CIS-acting DNA sequences. Proc Natl Acad Sci 1988;85:5092-6.
8. Kashiwagi A, Obata T, Suzaki M, et al. Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats. Metabolism 1992;41:1041-6.
9. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harpers Biochemistry, 25th edn. Norwalk: Appleton and Lange 2000:192-3, 225.
10. Vander Jagt DL, Hunsaker LA. Enzymology and Molecular Biology of Carbonyl Metabolism 4. New York: Plenum Press, 1993:279-88.
11. Kondoh Y, Kawase M, Ohmori S. D-lactate concentrations in blood, urine and sweat before and after exercise. Eur J Appl Physiol 1992;65:88-93.
12. Thornalley PJ. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans 1993;21:531-4. (Pubitemid 23167962)
13. Phillips SA, Mirlees D, Thornalley PJ. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor statil. Biochem Pharmacol 1993;46:805-11. (Pubitemid 23272760)
14. Beisswenger PJ, Howell SK, Smith K, Szwergold BS. Glyceraldehyde-3- phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 2003;1637:98-106. (Pubitemid 36071602)
15. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertens 1995;26:290-3.
16. Wu L, Juurlink BHJ. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertens 2002;39:809-14. (Pubitemid 34252881)
17. Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 2002;61:1184-91. (Pubitemid 34441784)
18. Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: Roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 2003;143-144:341-51. (Pubitemid 36253593)
19. Vander Jagt DL, Hassebrook RK, Hunsaker LA, Brown WM, Royer RE. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: Roles for glutathione in both enzymes and implications for diabetic complications. Chem Biol Interact 2001;130-132:549-62. (Pubitemid 32295843)
20. Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999;48:198-202. (Pubitemid 29019373)
21. Han Y, Randell E, Vasdev S, et al. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with type 1 diabetes. Mol Cell Biochem 2007;305:123-31. (Pubitemid 47517175)
22. Schauenstein E, Esterbauer H, Zollner H. Aldehydes in biological systems. In: Lagnado JR, ed. Aldehydes in Biological Systems: Their Natural Occurrence and Biological Activities. London: Pion Limited, 1977:1-7.
23. Baskaran S, Balasubramanian KA. Effect of methylglyoxal on protein thiol and amino groups in isolated rat enterocytes and colonocytes and activity of various brush border enzymes. Ind J Biochem Biophys 1990;27:13-7. (Pubitemid 20263561)
24. Mostafa AA, Randell EW, Vasdev SC, et al. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxymethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol Cell Biochem 2007;302:35-42. (Pubitemid 47202318)
25. Han Y, Randell E, Vasdev S, et al. Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with type 1 diabetes. Clin Biochem 2009;42:562-9.
26. McLellan AC, Phillips SA, Thornalley PJ. The assay of SD-lactoylglutathione in biological systems. Anal Biochem 1993;211:37-43.
27. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 2002;238:111-7. (Pubitemid 35023534)
28. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 2001;218:97-103. (Pubitemid 32294140)
29. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000;18:567-73. (Pubitemid 30303487)
30. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Mol Cell Biochem 1999;200:155-62. (Pubitemid 29490666)
31. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol Cell Biochem 2002;241:107-14. (Pubitemid 35385841)
32. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Met Cardiovasc Dis 2000;10:339-46.
33. Vasdev S, Longerich L, Gill V. Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 2004;37:1-9. (Pubitemid 37522118)
34. Wu L, Juurlink HJ. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 2001;19:1819-25. (Pubitemid 32924948)
35. Cabassi A, Dumont EC, Girouard H, et al. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 2001;19:1233-44. (Pubitemid 32595279)
36. Schauenstein E, Esterbauer H. Formation and properties of reactive aldehydes. Ciba Found Symp 1978;(67):225-44.
37. Lieber CS. Mechanism of ethanol induced hepatic injury. Pharmacol Ther 1990;46:1-41. (Pubitemid 20067878)
38. Beard KM, Shangari N, Wu B, OBrien PJ. Metabolism, not autoxidation, plays a role in a-oxoaldehyde- and reducing sugar-induced erythrocyte GSH depletion: Revelance for diabetes mellitus. Mol Cell Biochem 2003;252:331-8. (Pubitemid 37220763)
39. Ives HE. Ion transport defects and hypertension. Where is the link? Hypertens 1989;14:590-7. (Pubitemid 20020817)
40. Aoki K, Kawaguchi Y, Sato K, Kondo S, Yamamoto M. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1982;4:S298-S302. (Pubitemid 13173972)
41. Filo RS, Bohr DF, Ruegg JC. Glycerinated skeletal and smooth muscle: Calcium and magnesium dependence. Science 1965;147:1581-3.
42. Bohr DF. Vascular smooth muscle: Dual effect of calcium. Science 1963;139:597-9.
43. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis. Am J Physiol 1977;232:C165-C173. (Pubitemid 8134015)
44. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979;59:606-718. (Pubitemid 9236600)
45. Robinson BF. Altered calcium handling as a cause of primary hypertension. J Hypertens 1984;2:453-60. (Pubitemid 15205376)
46. + release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem 1989;264:21725-36. (Pubitemid 20028742)
47. + channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: Role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta 1990;1052:333-9. (Pubitemid 20147463)
48. Oba T, Yamaguchi M. Sulfhydryls on frog skeletal muscle membrane participate in contraction. Am J Physiol 1990;259:C709-C714. (Pubitemid 20385671)
49. Scherrer U, Sartori C. Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000;142:315-23. (Pubitemid 30230753)
50. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74. (Pubitemid 26081917)
51. Taddei S, Salvetti A. Direct effects of insulin on the arteriolar tone: Abnormality in insulin-resistant states? Nutr Metab Cardiovasc Dis 1996;6:178-86. (Pubitemid 126545346)
52. Ibarra M, Meneses A, Ransanz V, Castillo C, Hong E. Changes in endothelium-dependent vascular responses associated with spontaneous hypertension and age in rats. Arch Med Res 1995;26:S177-S183. (Pubitemid 26044951)
53. Lusher TF, Tanner FC, Dohi Y. Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol Toxicol 1992;70:S32-S39.
54. Degenhardt TP, Thorpe SR, Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol 1998;44:1139-45.
55. Selwood T, Thornalley PJ. Binding of methylglyoxal to albumin and formation of fluorescent adducts. Inhibition by arginine, N-acetylarginine and aminoguanidine. Biochem Soc Trans 1993;21:170S. (Pubitemid 23167838)
56. Brandwein HJ, Lewicki JA, Murad F. Reversible inactivation of guanylate cyclase by mixed disulfide formation. J Biol Chem 1981;256:2958-62. (Pubitemid 11067293)
57. Brouwers O, Niessen PM, Haenen G, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 2010;53:989-1000.
58. Stadtman TC. Selenum biochemistry. Ann Rev Biochem 1990;59:111-27.
59. Brooks BR, Klamerth OJ. Interaction of DNA with bifunctional aldehydes. European J Biochem 1968;5:178-82.
60. Thornalley P, Wolff S, Crabbe J, Stern A. The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim Biophys Acta 1984;797:276-87. (Pubitemid 14197639)
61. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 1985;227:629-38. (Pubitemid 15067738)
62. Benedetti A, Comporti M, Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 1980;620:281-96. (Pubitemid 11216247)
63. Dargel R. Lipid peroxidation - a common pathogenetic mechanism? Exp Toxic Pathol 1992;44:169-81.
64. Leoncini G, Maresca M, Buzzi E. Inhibition of the glycolytic pathway by methylgloxal in human platelets. Cell Biochem Function 1989;7:65-70. (Pubitemid 19017832)
65. Chatham JC, Gilbert HF, Radda GK. The metabolic consequences of hydroperoxide perfusion on the isolated rat heart. Eur J Biochem 1989;184:657-62. (Pubitemid 19260695)
66. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harpers Biochemistry, 25th edn. Norwalk: Appleton and Lange, 2000:193.
67. Leoncini G, Maresca M, Bonsignore A. The effect of methylglyoxal on the glycolytic enzymes. FEBS Lett 1980;117:17-8.
68. Novotny MV, Yancey MF, Stuart R, Wiesler D, Peterson RG. Inhibition of glycolytic enzymes by endogenous aldehydes: A possible relation to diabetic neuropathies. Biochem Biophys Acta 1994;1226:145-50. (Pubitemid 24182458)
69. Rosca MG, Monnier VM, Szweda LI, Weiss MF. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol 2001;283:F52-F59. (Pubitemid 34680471)
70. Amore A, Cappelli G, Cirina P, et al. Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant 2003;18:677-88. (Pubitemid 36432248)
71. Liu BF, Miyata S, Hirota Y, et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Intern 2003;63:947-57. (Pubitemid 36315572)
72. Golej J, Hoeger H, Radner W, Unfried G, Lubec G. Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci 1998;63:801-7. (Pubitemid 28383729)
73. +-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochem Biophys Acta 1986;862:8-16. (Pubitemid 17181064)
74. + exchange of cardiac sarcolemmal vesicles. J Membrane Biol 1986;94:217-25. (Pubitemid 17047467)
75. Needleman P, Jakschik B, Johnson EM Jr. Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther 1973;187:324-31.
76. + sequestration by the plasma membrane fraction from rat liver. FEBS 1983;163:136-9.
77. + sequestration during oxidative stress and its prevention by glutathione. J Biol Chem 1983;258:6390-3. (Pubitemid 13106814)
78. + homeostasis. Arch Biochem Biophys 1984;235:343-50. (Pubitemid 15158793)
79. + release channel in sarcoplasmic reticulum. J Biol Chem 1989;264:21737-47. (Pubitemid 20028743)
80. + concentration in human pancreatic islets and insulinoma cells. FEBS 1991;291:310-4.
81. Fridolf T, Ahrén B. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells. Biochem Biophys Res Commun 1993;191:1224-9. (Pubitemid 23231621)
82. Elliott AC, Trebilcock R, Yates AP, Best L. Stimulation of HIT-T15 insulinoma cells by glyceraldehyde does not require its metabolism. Eur J Biochem 1993;231:359-65. (Pubitemid 23106065)
83. Hirosumi J, Ouchi Y, Watanabe M, Kusunoki J, Nakamura T, Orimo H. Effect of superoxide and lipid peroxide on cytosolic free calcium concentration in cultured pig aortic endothelial cells. Biochem Biophys Res Commun 1988;152:301-7.
84. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V. Aldehyde induced hypertension in rats: Prevention by N-acetyl cysteine. Artery 1998;23:10-36. (Pubitemid 30045665)
85. Vasdev S, Wadhawan S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin B6 supplementation prevents ethanol induced hypertension in rats. Nutr Met Cardiovasc Dis 1999;9:55-63. (Pubitemid 129634400)
86. Vasdev S, Gill V, Longerich L, Parai S, Gadag V. Salt-induced hypertension in WKY rats: Prevention by a-lipoic acid supplementation. Mol Cell Biochem 2003;254:319-26. (Pubitemid 37483768)
87. Vasdev S, Ford CA, Longerich L, Parai S. A nutritional approach to prevent high blood pressure. In: Pierce G, ed. Atherosclerosis, Hypertension, and Diabetes. Boston: Kluwer Academic Publishers, 2003:187-96.
88. Vasdev S, Longerich L, Ford CA. Role of aldehydes in hypertension. In: Sharma BK, et al, eds. Adaptation Biology. New Delhi: Narosa Publishing House, 1997:326-39.
89. Meister A, Anderson ME, Hwang O. Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr 1986;5:137-51. (Pubitemid 16083224)
90. Lal KJ, Dakshinamurti K, Thliveris J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens 1996;14:355-63. (Pubitemid 26137633)